The emerging role of targeted therapies for advanced well-differentiated gastroenteropancreatic neuroendocrine tumors

JM Cloyd, B Konda, MH Shah… - Expert Review of Clinical …, 2019 - Taylor & Francis
Introduction: Gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are unique and
complex neoplasms, exhibiting a wide spectrum of diverse clinical behaviors. The …

New and emerging systemic therapy options for well-differentiated gastroenteropancreatic neuroendocrine tumors

SD Scoville, JM Cloyd, TM Pawlik - Expert opinion on …, 2020 - Taylor & Francis
Introduction: Well-differentiated gastroenteropancreatic (GEP) neuroendocrine tumors
(NETs) are a heterogeneous group of neoplasms with a wide range of clinical behavior …

Systemic therapies for advanced gastroenteropancreatic neuroendocrine tumors

D Patel, D Chan, G Cehic, N Pavlakis… - Expert Review of …, 2016 - Taylor & Francis
Introduction: Neuroendocrine tumors are a heterogeneous group of malignancies,
characterised by production of hormones and vasoactive peptides. The incidence of …

Advances in the treatment of gastroenteropancreatic neuroendocrine tumors

PL Kunz, GA Fisher - Clinical and experimental gastroenterology, 2010 - Taylor & Francis
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a rare and heterogeneous
class of neoplasms. While surgical resection is the mainstay of treatment, non-surgical …

[HTML][HTML] New therapeutic approaches to metastatic gastroenteropancreatic neuroendocrine tumors: A glimpse into the future

EU Cidon - World journal of gastrointestinal oncology, 2017 - ncbi.nlm.nih.gov
Neuroendocrine (NE) gastroenteropancreatic tumors are a heterogeneous group of
neoplasias arising from neuroendocrine cells of the embryological gut. Their incidence have …

[HTML][HTML] Recent advances in the management of gastroenteropancreatic neuroendocrine tumors: insights from the 2017 ASCO Gastrointestinal Cancers Symposium

R Iyer, AT Phan, JP Boudreaux - 2017 - hematologyandoncology.net
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare malignancies that
originate in the gastrointestinal system. GEP-NETs are typically indolent, but tumors known …

Update in the management of gastroenteropancreatic neuroendocrine tumors

AJH Sedlack, DG Varghese, A Naimian… - Cancer - Wiley Online Library
Neuroendocrine neoplasms are a diverse group of neoplasms that can occur in various
areas throughout the body. Well‐differentiated neuroendocrine tumors (NETs) most often …

Combination systemic therapies in advanced well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs): A comprehensive review of clinical trials …

LN Diamantopoulos, M Kalligeros, TR Halfdanarson… - Biology, 2023 - mdpi.com
Simple Summary This comprehensive review explores evolving systemic combination
regimens for advanced well-differentiated gastroenteropancreatic neuroendocrine tumors …

Novel therapeutic agents for the treatment of gastroenteropancreatic neuroendocrine tumors

ME Pavel, B Wiedenmann - Hormone and metabolic research, 2011 - thieme-connect.com
Neuroendocrine tumors (NET) are frequently diagnosed late and not amenable to curative
surgery due to metastatic disease to the liver and lymph nodes. The disease is complex and …

New pharmacologic therapies for gastroenteropancreatic neuroendocrine tumors

B Lawrence, BI Gustafsson, M Kidd… - Gastroenterology …, 2010 - gastro.theclinics.com
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are more common than
previously thought and second only to colorectal cancers as the most prevalent …